Skip to main content
Jason Farrar, MD, Pediatric Hematology & Oncology, Little Rock, AR, Arkansas Children's Hospital

JasonEliFarrarMDFAAP(He/Him)

Pediatric Hematology & Oncology Little Rock, AR

Associate Professor, Pediatrics, University of Arkansas COM

Dr. Farrar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Farrar's full profile

Already have an account?

Summary

  • Dr. Jason Farrar is a pediatric hematologist/oncologist in Little Rock, AR and is affiliated with Arkansas Children's Hospital and UAMS Medical Center. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine, completed residency training at Children's Hospital of Wisconsin, and hematology/oncology fellowship at Johns Hopkins and the National Cancer Institute. He has been in practice 21 years. He is experienced in bone marrow failure syndromes, acute myeloid leukemia, acute lymphoblastic leukemia, and pediatric hematologic oncology. He has more than 40 publications and over 2000 citations.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2003 - 2007
  • Pediatric Oncology Branch, National Cancer Institute
    Pediatric Oncology Branch, National Cancer InstitutePediatric Oncology, Pediatric Oncology, 2003 - 2006
  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsResidency, Pediatrics, 2000 - 2003
  • University of Arkansas For Medical Sciences College of Medicine
    University of Arkansas For Medical Sciences College of MedicineClass of 2000

Certifications & Licensure

  • AR State Medical License
    AR State Medical License 2012 - 2025
  • MD State Medical License
    MD State Medical License 2003 - 2012
  • WI State Medical License
    WI State Medical License 2001 - 2007
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Discovery of Novel IL3RA (CD123) Isoforms By Long Read Transcriptomics, Heterogeneous Expression Among AML Patient Cohorts and the Implications for Anti-CD123 Therapeu...
    Jason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene _ a COG/Tpaml Study
    Jason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies
    Jason E. Farrar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Arkansas Children's Hospital Becomes Nation's First Therapeutic Site in Launch of Groundbreaking Clinical Trial for Pediatric Acute Leukemia
    Arkansas Children's Hospital Becomes Nation's First Therapeutic Site in Launch of Groundbreaking Clinical Trial for Pediatric Acute LeukemiaJune 29th, 2022
  • ‘Remarkable’ Distinctions in Pediatric Leukemia Point Toward Improved Treatment
    ‘Remarkable’ Distinctions in Pediatric Leukemia Point Toward Improved TreatmentFebruary 1st, 2023

Grant Support

  • Mechanisms of Erythroid Remission in Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2020–2023
  • Center for Pediatric Translational ResearchNational Institute of General Medical Sciences2017–2020
  • Functional Analysis Of Rpl35a Alterations In Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2009–2012

Professional Memberships

Hospital Affiliations